DE60112922D1 - Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten - Google Patents

Zusammensetzungen enthaltend ein benzamiddisulfid-derivat zur behandlung allergischer krankheiten

Info

Publication number
DE60112922D1
DE60112922D1 DE60112922T DE60112922T DE60112922D1 DE 60112922 D1 DE60112922 D1 DE 60112922D1 DE 60112922 T DE60112922 T DE 60112922T DE 60112922 T DE60112922 T DE 60112922T DE 60112922 D1 DE60112922 D1 DE 60112922D1
Authority
DE
Germany
Prior art keywords
disulfid
benzamid
derivative
treatment
allergic diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60112922T
Other languages
English (en)
Other versions
DE60112922T2 (de
Inventor
T Miller
R Hellberg
Zixia Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of DE60112922D1 publication Critical patent/DE60112922D1/de
Publication of DE60112922T2 publication Critical patent/DE60112922T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE60112922T 2000-05-19 2001-04-25 Zusammensetzungen enthaltend ein benzamiddisulfidderivat zur behandlung allergischer krankheiten Expired - Fee Related DE60112922T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20608300P 2000-05-19 2000-05-19
US206083P 2000-05-19
PCT/US2001/013399 WO2001089493A2 (en) 2000-05-19 2001-04-25 Compositions containing a benzamide disulfide derivative for treating allergic diseases

Publications (2)

Publication Number Publication Date
DE60112922D1 true DE60112922D1 (de) 2005-09-29
DE60112922T2 DE60112922T2 (de) 2006-01-26

Family

ID=22764902

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60112922T Expired - Fee Related DE60112922T2 (de) 2000-05-19 2001-04-25 Zusammensetzungen enthaltend ein benzamiddisulfidderivat zur behandlung allergischer krankheiten

Country Status (19)

Country Link
US (1) US6492418B2 (de)
EP (1) EP1284722B1 (de)
JP (1) JP2003534274A (de)
KR (1) KR20020093981A (de)
CN (1) CN1172666C (de)
AR (1) AR029085A1 (de)
AT (1) ATE302601T1 (de)
AU (2) AU2001253807B2 (de)
BR (1) BR0110852A (de)
CA (1) CA2407767A1 (de)
DE (1) DE60112922T2 (de)
DK (1) DK1284722T3 (de)
ES (1) ES2243482T3 (de)
HK (1) HK1049614B (de)
MX (1) MXPA02011482A (de)
PL (1) PL363102A1 (de)
PT (1) PT1284722E (de)
WO (1) WO2001089493A2 (de)
ZA (1) ZA200208838B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011480A (es) * 2000-05-19 2003-06-06 Alcon Inc Derivados de disulfuro de anilina para tratar enfermedades alergicas.
MXPA06014648A (es) * 2004-06-28 2007-02-12 Alcon Inc Formulaciones topicas para tratar pacedimientos alergicos.
KR100984814B1 (ko) 2009-12-21 2010-10-01 삼성전자주식회사 수평형 사출 금형 시스템 및 이를 이용하는 사출 성형 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (de) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
DE2862014D1 (en) * 1977-07-09 1982-10-28 Michael Fred Joyce Carriers for containers, apparatus and method for applying same to containers
EP0006227B1 (de) 1978-06-16 1984-12-27 Kyowa Hakko Kogyo Co., Ltd 2,2'-Dithiobis-benzamidderivate enthaltende antithrombische pharmazeutische Präparate und 2,2'-Dithiobis-benzamidderivate
JPS55324A (en) * 1978-06-16 1980-01-05 Kyowa Hakko Kogyo Co Ltd Antithrombotic
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU2458697A (en) 1996-04-18 1997-11-07 Alcon Laboratories, Inc. Calcium channel blockers as human conjunctival mast cell degranulation inhibitors for treating ocular allergic conditions
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) * 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
KR20020093981A (ko) 2002-12-16
PT1284722E (pt) 2005-10-31
DE60112922T2 (de) 2006-01-26
AU2001253807B2 (en) 2005-02-17
BR0110852A (pt) 2003-02-11
WO2001089493A3 (en) 2002-03-28
ZA200208838B (en) 2003-10-31
CN1172666C (zh) 2004-10-27
ATE302601T1 (de) 2005-09-15
AR029085A1 (es) 2003-06-04
ES2243482T3 (es) 2005-12-01
EP1284722A2 (de) 2003-02-26
CA2407767A1 (en) 2001-11-29
HK1049614B (zh) 2005-11-18
PL363102A1 (en) 2004-11-15
WO2001089493A2 (en) 2001-11-29
MXPA02011482A (es) 2003-06-06
US20020065281A1 (en) 2002-05-30
JP2003534274A (ja) 2003-11-18
CN1429107A (zh) 2003-07-09
DK1284722T3 (da) 2005-09-19
EP1284722B1 (de) 2005-08-24
HK1049614A1 (en) 2003-05-23
US6492418B2 (en) 2002-12-10
AU5380701A (en) 2001-12-03

Similar Documents

Publication Publication Date Title
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE502004008604D1 (de) Pyrrolopyridin-substitutierte benzol-derivate zur behandlung kardiovaskulärer erkrankungen
ATE390407T1 (de) Phenethanolamin-derivate zur behandlung von atemwegserkrankungen
DE60230425D1 (de) Phenethanolamin-derivate zur behandlung von erkrankungen der atemwege
DE60335560D1 (de) Zusammensetzungen enthaltend zitronensäure zur behandlung von nagelpilzerkrankungen
DE602004028763D1 (de) Te zur behandlung von virenerkrankungen
FIU20060389U0 (fi) Luusairauksien hoito
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602004029580D1 (de) Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen
DE60303238D1 (de) Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
DE60031710D1 (de) Fettsäurederivat zur behandlung von externen sekretionsstörungen
NO20031443L (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
IL161070A0 (en) Compositions for the treatment of infectious diseases
ATE302017T1 (de) Zusammensetzung zur behandlung von durch arterielle irrigationsdefekt gewebeschäden
ATE313540T1 (de) Heterozyklische verbindungen zur behandlung von harnwegserkrankungen
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE60216457D1 (de) Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee